The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 01, 2021

Filed:

Aug. 04, 2017
Applicant:

Marine Biomedical Research Institute of Qingdao Co., Ltd., Shandong, CN;

Inventors:

Wenbao Li, Shandong, CN;

Xianjun Qu, Shandong, CN;

Feng Li, Shandong, CN;

Liang Zhang, Shandong, CN;

Shixiao Wang, Shandong, CN;

Zhiyu Song, Shandong, CN;

Feng Wang, Shandong, CN;

Chong Yang, Shandong, CN;

Huashi Guan, Shandong, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 17/07 (2006.01); A61K 31/7048 (2006.01); A61P 35/00 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01); C07D 311/64 (2006.01); C07H 1/00 (2006.01);
U.S. Cl.
CPC ...
C07H 17/07 (2013.01); A61K 31/7048 (2013.01); A61P 1/00 (2018.01); A61P 1/04 (2018.01); A61P 35/00 (2018.01); C07D 311/64 (2013.01); C07H 1/00 (2013.01); Y02P 20/55 (2015.11);
Abstract

The present invention provides a myricetin derivative, a preparation method thereof, a pharmaceutical composition containing the same, an application thereof for treating colitis, preventing and treating colitis-associated tumorigenesis and treating colorectal cancer, and an application thereof in preparing a composition for modulating activities of endoplasmic reticulum stress signaling molecules. The myricetin derivative disclosed herein has excellent water solubility, and has biological activities including inhibition of colitis, prevention and treatment of colitis-associated tumorigenesis, and treatment of colorectal cancer. The preparation method disclosed herein uses myricetrin as starting material which is economical and easily available. With the merits of low cost, high yield, high product purity and suitability for large-scale industrial production, the preparation method disclosed herein represents significant market value and economic prospects.


Find Patent Forward Citations

Loading…